Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Congenital Posterior Urethral Valves (ICD-10 Code: Q64.2)
Summary
Congenital posterior urethral valves are rare structural abnormalities of the urethra present at birth, characterized by obstructive membranes or folds that block urine flow from the bladder. This condition primarily affects male infants and can lead to urinary tract obstruction, kidney damage, and other complications if untreated.
Causes
The exact cause is not fully understood, but it is believed to result from abnormal development of the urethra during embryonic growth. Genetic and environmental factors may contribute, though specific triggers are often not identifiable.
Risk Factors
- Male gender (nearly exclusive occurrence).
- Family history of congenital urinary tract abnormalities.
- Associated congenital anomalies (e.g., vesicoureteral reflux, renal dysplasia).
Symptoms
- Weak or intermittent urine stream.
- Difficulty urinating or urinary retention.
- Abdominal distension or palpable bladder.
- Urinary tract infections.
- Signs of kidney dysfunction (e.g., elevated creatinine, poor growth).
Diagnosis
Diagnosis typically involves imaging studies such as prenatal or postnatal ultrasound to detect bladder distension, thickened bladder walls, or hydronephrosis. Voiding cystourethrography (VCUG) may confirm the presence of valves, while renal function tests assess kidney involvement.
Treatment Options
- Surgical removal of the valves via cystoscopy.
- Temporary urinary diversion (e.g., catheterization) to relieve obstruction.
- Antibiotics to prevent infections.
- Long-term monitoring of renal function and bladder health.
Prognosis and Follow-Up
Prognosis depends on the severity of obstruction and timing of intervention. Early treatment improves outcomes, but some patients may develop chronic kidney disease or require ongoing urological care. Regular follow-up with imaging and renal function tests is recommended.
Complications
- Chronic kidney disease or renal failure.
- Vesicoureteral reflux.
- Urinary incontinence.
- Recurrent urinary tract infections.
- Bladder dysfunction.
Lifestyle & Prevention
No specific preventive measures exist, as the condition is congenital. Maintaining good hydration and prompt treatment of infections may support urinary tract health.
When to Seek Professional Help
Seek immediate medical attention if symptoms like difficulty urinating, abdominal pain, or signs of infection (e.g., fever, foul-smelling urine) occur. Early evaluation is critical to prevent irreversible kidney damage.
Tips for Medical Coders
Document the presence of obstructive urethral membranes, associated anomalies (e.g., renal dysplasia), and any surgical interventions. Ensure specificity in clinical notes to support accurate coding. Note that Q64.2 is used exclusively for congenital posterior urethral valves and should not be confused with acquired urethral strictures.
Medical Policies and Guidelines
Related policies from health plans
Q64.2 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.